Company research / SRPT
Sarepta Therapeutics, Inc. (SRPT)
- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
For the year ended 2025-12-31, Sarepta Therapeutics, Inc. reported revenue of $2.20B. Revenue grew 15.6% from the prior annual period.
Key ratios (year ended 2025-12-31)
-31.8%
Operating margin
-32.5%
Net margin
-62.5%
Return on year-end equity
15.6%
Revenue growth (YoY)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.